Grape King Bio Ltd (TPE:1707)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
122.50
-0.50 (-0.41%)
Jul 10, 2025, 2:38 PM CST
-19.41%
Market Cap 18.15B
Revenue (ttm) 11.06B
Net Income (ttm) 1.40B
Shares Out 148.14M
EPS (ttm) 9.38
PE Ratio 13.06
Forward PE n/a
Dividend 6.90 (5.63%)
Ex-Dividend Date Jun 23, 2025
Volume 277,502
Average Volume 166,811
Open 122.00
Previous Close 122.50
Day's Range 119.50 - 122.50
52-Week Range 119.50 - 158.00
Beta 0.45
RSI 25.78
Earnings Date Aug 14, 2025

About Grape King Bio

Grape King Bio Ltd, together with its subsidiaries, produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally. It operates through Multi-Level Marketing; Distributors; Original Design Manufacturer/Original Equipment Manufacturer; and Sales Channel segments. The company offers Chinese herbal medicines, probiotics, energy drinks, and health food supplements for gastrointestinal health, immunity regulation, female beauty, and health care. It also provides functio... [Read more]

Sector Healthcare
Founded 1969
Employees 501
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 1707
Full Company Profile

Financial Performance

In 2024, Grape King Bio's revenue was 11.16 billion, an increase of 4.93% compared to the previous year's 10.64 billion. Earnings were 1.45 billion, a decrease of -0.30%.

Financial Statements

News

There is no news available yet.